Similar articles

• Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.

  Dowlatshahi D, Hill MD. Dowlatshahi D, et al. Expert Rev Cardiovasc Ther. 2009 May;7(5):459-64. doi: 10.1586/erc.09.3. Expert Rev Cardiovasc Ther. 2009. PMID: 19419253
• Preventing cerebrovascular and cardiovascular events after stroke: eprosartan or nitrendipine?

  Johnston SC. Johnston SC. Nat Clin Pract Neurol. 2006 Jan;2(1):24-5. doi: 10.1038/ncpneuro0090. Nat Clin Pract Neurol. 2006. PMID: 16932517 No abstract available.
• [Control of blood pressure in prevention of hypertensive end-organ damage].

  Kido M, Ando K, Fujita T. Kido M, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:389-93. Nihon Rinsho. 2004. PMID: 15171405 Review. Japanese. No abstract available.
• [Policy of antihypertensive therapy in arterial hypertension in the elderly. II].

  Gurevich MA. Gurevich MA. Klin Med (Mosk). 2002;80(9):9-13. Klin Med (Mosk). 2002. PMID: 12416217 Review. Russian. No abstract available.
• [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].

  Higashiura K. Higashiura K. Nihon Rinsho. 2004 Mar;62 Suppl 3:623-7. Nihon Rinsho. 2004. PMID: 15171446 Review. Japanese. No abstract available.